CIBC Asset Management’s Abiomed Inc ABMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,040
| Closed | -$1.48M | – | 1304 |
|
|
2022
Q3 | $1.48M | Buy |
6,040
+525
| +10% | +$129K | 0.01% | 600 |
|
|
2022
Q2 | $1.37M | Buy |
5,515
+1,198
| +28% | +$297K | 0.01% | 602 |
|
|
2022
Q1 | $1.43M | Buy |
4,317
+44
| +1% | +$14.6K | 0.01% | 625 |
|
|
2021
Q4 | $1.54M | Buy |
4,273
+237
| +6% | +$85.1K | 0.01% | 601 |
|
|
2021
Q3 | $1.31M | Buy |
4,036
+126
| +3% | +$41K | 0.01% | 616 |
|
|
2021
Q2 | $1.22M | Buy |
3,910
+43
| +1% | +$13.4K | ﹤0.01% | 633 |
|
|
2021
Q1 | $1.23M | Sell |
3,867
-79
| -2% | -$25.2K | 0.01% | 613 |
|
|
2020
Q4 | $1.28M | Hold |
3,946
| – | – | 0.01% | 581 |
|
|
2020
Q3 | $1.09M | Buy |
3,946
+75
| +2% | +$20.8K | 0.01% | 564 |
|
|
2020
Q2 | $935K | Buy |
3,871
+64
| +2% | +$15.5K | 0.01% | 579 |
|
|
2020
Q1 | $553K | Sell |
3,807
-297
| -7% | -$43.1K | ﹤0.01% | 611 |
|
|
2019
Q4 | $700K | Buy |
4,104
+61
| +2% | +$10.4K | ﹤0.01% | 664 |
|
|
2019
Q3 | $719K | Sell |
4,043
-50
| -1% | -$8.89K | ﹤0.01% | 657 |
|
|
2019
Q2 | $1.07M | Buy |
4,093
+85
| +2% | +$22.1K | 0.01% | 586 |
|
|
2019
Q1 | $1.15M | Buy |
4,008
+156
| +4% | +$44.6K | 0.01% | 570 |
|
|
2018
Q4 | $1.25M | Sell |
3,852
-4
| -0.1% | -$1.3K | 0.01% | 491 |
|
|
2018
Q3 | $1.73M | Buy |
3,856
+150
| +4% | +$67.5K | 0.01% | 461 |
|
|
2018
Q2 | $1.52M | Buy |
3,706
+2,238
| +152% | +$915K | 0.01% | 489 |
|
|
2018
Q1 | $427K | Hold |
1,468
| – | – | ﹤0.01% | 744 |
|
|
2017
Q4 | $275K | Hold |
1,468
| – | – | ﹤0.01% | 845 |
|
|
2017
Q3 | $248K | Buy |
+1,468
| New | +$248K | ﹤0.01% | 870 |
|